EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy

FIGURE 1 Journal of Thoracic Oncology 2015 101720 -1725 DOI: (10. 1097/JTO. 0000000675) Copyright

FIGURE 2 Journal of Thoracic Oncology 2015 101720 -1725 DOI: (10. 1097/JTO. 0000000675) Copyright

FIGURE 3 Journal of Thoracic Oncology 2015 101720 -1725 DOI: (10. 1097/JTO. 0000000675) Copyright

FIGURE 4 Journal of Thoracic Oncology 2015 101720 -1725 DOI: (10. 1097/JTO. 0000000675) Copyright

Slides: 5

EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma Kosuke Tanaka, MD, Toyoaki Hida, MD, Ph. D, Yuko Oya, MD, Tomoyo Oguri, MD, Ph. D, Tatsuya Yoshida, MD, Junichi Shimizu, MD, Ph. D, Yoshitsugu Horio, MD, Ph. D, Akito Hata, MD, Reiko Kaji, MD, Shiro Fujita, MD, Ph. D, Yoshitaka Sekido, MD, Ph. D, Takeshi Kodaira, MD, Ph. D, Masaki Kokubo, MD, Ph. D, Nobuyuki Katakami, MD, Ph. D, Yasushi Yatabe, MD, Ph. D Journal of Thoracic Oncology Volume 10 Issue 12 Pages 1720 -1725 (December 2015) DOI: 10. 1097/JTO. 0000000675 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions